When Fat Can No Longer Adapt
Personal Fat Thresholds and the Bioenergetic Cost of Storing Energy
Why metabolic health depends on how well our fat tissue adapts—not simply how much fat we carry.
Two people may have the same body mass index (BMI), yet their metabolic health can be remarkably different.
One may carry substantial body fat while maintaining relatively normal blood glucose, triglycerides, and liver function. Another may develop fatty liver, insulin resistance, or type 2 diabetes despite having a BMI within the conventional reference range.
Why does this happen?
A compelling explanation is that individuals differ in their capacity to store, mobilize, and manage fat. But the question goes deeper: What determines how much fat our bodies can safely accommodate, and why does that capacity deteriorate?
A recent review published in Science, titled “When fat adapts: From physiological remodeling to disease”, by Karima Drareni and Patrick Seale (2026), provides important insights into these questions.
The authors argue that adipose tissue is far more than a passive storage compartment. It is a dynamic, metabolically active organ that constantly remodels itself to meet changing physiological demands.
Their findings connect with the Personal Fat Threshold hypothesis and invite a further interpretation through our proposed framework of bioenergetic impedance, adaptation, and incomplete recovery.
Fat Is Not Simply Stored Energy
We often think of body fat as a reservoir of excess calories. When we eat more than we expend, fat accumulates. When we eat less or exercise, stored fat is mobilized.
While this description is broadly correct, it overlooks the complexity of the tissue responsible for these processes.
Adipose tissue contains not only fat cells, or adipocytes, but also blood vessels, immune cells, nerve fibers, progenitor cells, and a supporting extracellular matrix.
Together, these components allow fat tissue to perform several essential functions:
Store excess energy safely after meals.
Release fatty acids when other tissues require fuel.
Help regulate circulating glucose and lipid concentrations.
Produce hormones and communicate with other organs.
Generate heat through specialized brown and beige adipocytes.
Adapt its cellular structure and blood supply as physiological demands change.
Healthy adipose tissue must therefore do more than accumulate fat. It must continuously coordinate energy storage, energy release, tissue maintenance, and recovery.
The Science review describes how feeding, fasting, exercise, and cold exposure stimulate different forms of adaptive remodeling.
During feeding, insulin promotes lipid storage. During fasting and exercise, adipocytes release fatty acids to support energy requirements elsewhere in the body. During recovery, those stores may be replenished.
These processes are not competing abnormalities. They are different phases of normal physiological function.
Metabolic health requires the flexibility to move between them.
Problems emerge when these transitions become constrained or when the tissue can no longer adapt adequately to changing demands.
Two Ways to Expand Fat Tissue: More Cells or Larger Cells?
One of the most interesting discussions in the review concerns how adipose tissue expands.
When the body needs additional fat-storage capacity, there are two principal possibilities.
Hyperplasia: Increasing the number of adipocytes
New fat cells develop from precursor cells, allowing incoming lipids to be distributed across a larger population of adipocytes.
This can preserve relatively small, insulin-responsive cells while expanding overall storage capacity.
However, producing new adipocytes requires coordinated tissue remodeling, including progenitor differentiation, vascular development, and extracellular matrix organization.
Hypertrophy: Enlarging existing adipocytes
Alternatively, existing adipocytes can accommodate more triglycerides by increasing their size.
This is a normal and useful response, particularly during early expansion. However, individual cells cannot enlarge indefinitely without physiological consequences.
As adipocytes become excessively enlarged, they may develop organelle stress, altered insulin signaling, and impaired lipid handling. Their surrounding blood vessels and supporting tissue may also become insufficient to sustain further expansion.
Neither hyperplasia nor hypertrophy is inherently pathological. Healthy adipose tissue can use both. The balance between them, however, matters greatly.
The review highlights evidence that individuals whose adipose tissue can recruit new cells and expand appropriately may tolerate greater fat accumulation without developing equivalent metabolic complications.
In contrast, limited adipogenic capacity can force greater reliance on existing adipocytes and increase the likelihood of pathological remodeling.
This provides a cellular explanation for a familiar clinical observation: the amount of fat someone carries does not necessarily reveal how well their fat tissue functions.
Personal Fat Threshold: Why One Person's Safe Fat Level May Be Another's Problem
The concept of a Personal Fat Threshold was proposed by Roy Taylor and Rury Holman in 2015.
Their hypothesis suggests that every individual has a different tolerance for fat accumulation before excess lipid begins to disrupt metabolic function.
When adipose tissue can accommodate incoming lipids effectively, it protects organs such as the liver, pancreas, and skeletal muscle from inappropriate lipid deposition.
When storage capacity becomes insufficient relative to demand, excess fatty acids and triglycerides can increasingly accumulate or circulate outside their intended storage compartments.
This helps explain why type 2 diabetes can occur in individuals who are not conventionally obese.
In the ReTUNE study published in 2023, researchers investigated 20 people with type 2 diabetes whose BMI was below 27 kg/m².
Following structured weight reduction, 14 of the 20 participants achieved sustained diabetes remission during the study. This was accompanied by reductions in liver fat and hepatic triglyceride export, together with improvements in metabolic function.
These findings supported the hypothesis that diabetes can emerge when an individual exceeds their own capacity to accommodate fat, rather than simply when they cross a population-defined BMI threshold.
Yet the Science review allows us to ask another question.
Is the personal fat threshold fixed, or can it change as adipose tissue adapts, ages, becomes stressed, or recovers?
Genetics and developmental factors undoubtedly influence adipose distribution and storage capacity. However, vascularization, progenitor function, inflammation, fibrosis, and cellular senescence can change throughout life.
This suggests that personal fat tolerance may have an important dynamic component.
Someone who could accommodate a particular amount of body fat earlier in life might not necessarily maintain the same capacity decades later.
The reverse may also be possible: improvements in tissue function and recovery could enhance metabolic tolerance, although the extent to which an individual's threshold can be restored remains uncertain.
When an Expanding Fat Cell Reaches Its Physiological Limits
Consider an adipocyte that continues to enlarge because new fat-cell formation is insufficient to accommodate incoming lipids.
Initially, its expansion may be successful. More triglycerides can be stored, helping maintain systemic energy balance.
But continued enlargement creates additional physiological demands.
The cell must maintain its membrane, organelles, signaling systems, and internal metabolic processes. The surrounding tissue must provide adequate oxygen, nutrients, blood flow, structural support, and waste removal.
As the cell enlarges, the distance between its interior and the nearest capillary can increase. At the tissue level, vascular development may fail to keep pace with expansion.
An important distinction emerges here: having an abundant supply of stored energy does not necessarily mean a cell has an adequate capacity to support all the biological work required to remain functional.
Triglycerides represent stored energetic potential. They do not, by themselves, guarantee adequate oxygen delivery, mitochondrial throughput, nutrient availability, or tissue maintenance.
When supply and demand become mismatched, cells activate compensatory responses.
One example involves hypoxia-inducible factor 1-alpha, or HIF-1α.
HIF-1α participates in cellular responses to reduced oxygen availability. In many tissues, hypoxia-related signaling can promote vascular endothelial growth factor (VEGF), which supports the formation of new blood vessels.
This seems like a logical adaptation: if expanding tissue requires more oxygen and nutrients, increasing vascular supply could help meet that demand.
However, the process does not always resolve successfully.
Experimental studies have demonstrated that persistent HIF-1α activation in adipose tissue can promote fibrosis and inflammation rather than producing sufficient new blood vessels.
This creates a potentially damaging cycle. Inadequate vascular adaptation contributes to cellular stress, while fibrosis makes the surrounding tissue increasingly rigid and less capable of further remodeling.
Importantly, human studies of adipose oxygen tension have produced mixed findings. Not all dysfunctional adipose tissue is demonstrably hypoxic. Reduced oxygen consumption, altered blood flow, and inflammatory signaling may also be involved.
The broader problem is therefore not necessarily oxygen deficiency alone.
It is the mismatch between metabolic requirements and the tissue's capacity to deliver, utilize, and recover the resources required for adaptation.
Could Insulin Resistance Begin as an Attempt to Limit Further Expansion?
This brings us to one of the most intriguing possibilities.
Insulin normally promotes energy storage in adipocytes. It facilitates glucose uptake, supports triglyceride synthesis, and suppresses the release of stored fatty acids.
But what happens when an adipocyte is already excessively enlarged and its capacity to accommodate additional lipids becomes constrained?
One possibility is that reduced responsiveness to some insulin actions could limit additional substrate handling under conditions of cellular stress.
From an adaptive perspective, this raises an interesting question: could certain changes associated with insulin resistance initially reduce pressure on an already compromised cell?
This interpretation is plausible, but it remains a hypothesis. Insulin resistance should not be understood as a conscious or universally coordinated decision by adipocytes to protect themselves.
Moreover, insulin resistance is not necessarily an all-or-nothing switch. Research demonstrates that adipocytes may develop resistance to insulin-stimulated glucose metabolism while retaining some of insulin's ability to suppress lipolysis.
Nevertheless, in metabolically dysfunctional adipose tissue, regulation of fat mobilization can become impaired.
Normally, lipolysis is coordinated with physiological demand. Fatty acids are released during fasting or exercise and used by tissues that require fuel.
Under dysfunctional conditions, fatty acid release may become poorly regulated, including inadequate suppression when insulin levels are elevated.
This can increase fatty acid delivery to the liver.
When the liver receives more fatty acids than it can safely oxidize, redistribute, or export, hepatic triglyceride accumulation may increase. Enhanced triglyceride packaging into very-low-density lipoproteins (VLDL) can also contribute to elevated circulating triglycerides.
Thus, elevated triglycerides and fatty liver can be understood partly as manifestations of disrupted lipid handling across interacting organs—not merely as evidence of excessive dietary fat consumption.
A response that might initially limit cellular storage pressure can therefore become harmful when it contributes to excessive lipid delivery elsewhere.
The distinction between adaptive mobilization and persistent, poorly regulated lipid release is essential.
Our Bioenergetic Interpretation: When Adaptation Becomes Too Costly
The Science review describes the cellular and structural changes underlying adipose tissue remodeling. Our proposed bioenergetic framework offers a complementary way to interpret how these changes may evolve over time.
In our earlier work on Exposure-Related Malnutrition (ERM), we proposed that sustained physiological demands can compete for the energy and nutrients required for maintenance, repair, and recovery.
We subsequently developed the concept of bioenergetic impedance to describe circumstances in which energetic demands exceed the available capacity to conduct, transform, buffer, and recover from those demands.
This does not simply mean that the body runs out of calories or that cellular ATP levels must become depleted.
Instead, physiological capacity may become constrained at several different points: substrate delivery, oxygen transport, mitochondrial metabolism, cellular signaling, structural remodeling, or recovery.
Applying this perspective to adipose tissue suggests a possible progression.
First, adaptation maintains function.
Fat cells enlarge, new adipocytes may develop, and vascular and immune components remodel to accommodate increasing lipid-storage demands.
Second, compensatory demands increase.
As tissue expansion continues, maintaining adequate perfusion, metabolic regulation, and structural integrity may require progressively greater or more complex adaptation.
Third, incomplete adaptation creates persistent constraints.
If new adipocytes cannot form adequately, vascular supply does not keep pace, or fibrosis and inflammation interfere with normal remodeling, the tissue becomes less flexible.
Fourth, lipid handling becomes increasingly dysregulated.
Adipose tissue may lose some of its capacity to store lipids safely, regulate lipolysis, and respond appropriately to feeding and fasting.
Finally, dysfunction may become systemic.
Fatty acid spillover, ectopic lipid deposition, altered endocrine signaling, and inflammatory responses can affect the liver, pancreas, skeletal muscle, cardiovascular system, and other organs.
This progression is not inevitable or strictly linear. Different mechanisms may dominate in different individuals, and some responses may remain adaptive.
Nevertheless, it offers an important proposition: metabolic dysfunction may emerge when the requirements of continued adaptation exceed the tissue's capacity to sustain that adaptation and recover.
This proposed bioenergetic interpretation is consistent with several mechanisms documented in the review, but it has not been established as their common underlying cause. Demonstrating that would require direct measurements of physiological demand, tissue throughput, adaptive capacity, and recovery over time.
What About Aging, Chronic Stress, and Environmental Exposures?
The Science review also describes how aging changes adipose tissue independently of major changes in body weight.
With increasing age, adipocyte progenitors can become senescent, extracellular matrix fibrosis can accumulate, and brown and beige fat activity can decline.
Meanwhile, fat distribution often shifts toward visceral and ectopic compartments.
These changes can reduce the tissue's adaptability even when BMI remains relatively stable.
From our broader ERM perspective, this raises the possibility that cumulative physiological demands may further influence adipose reserve.
Daily life exposes the body to overlapping metabolic, behavioral, psychosocial, inflammatory, and environmental challenges. Responding to them requires coordinated activity across multiple physiological systems.
If those demands persist while recovery remains incomplete, resources available for long-term tissue maintenance and remodeling may become constrained.
Could this contribute to declining adipose plasticity and a progressively lower personal fat tolerance?
It is a testable possibility, but the review does not directly investigate cumulative environmental exposures or establish that systemic resource allocation causes adipose dysfunction.
What it does demonstrate is that adipose tissue performance depends on a complex network of cells and supporting systems, many of which can deteriorate under sustained pathological conditions.
This makes a broader systems-level interpretation worth investigating.
Weight Loss Is Helpful, but Does It Restore Fat Tissue Health?
One particularly important observation in the review is that weight loss does not necessarily reverse every structural and cellular consequence of previous obesity.
Weight reduction can improve insulin sensitivity, decrease adipocyte size, and relieve metabolic stress.
However, some fibrotic, immune, and molecular changes may persist.
Experimental studies also suggest that adipose tissue can retain a form of biological memory after weight loss, potentially influencing its response to subsequent weight regain.
The clinical implications remain uncertain, especially regarding how these findings translate from animals to humans.
Nevertheless, the concept introduces an important distinction between reducing metabolic burden and restoring adaptive competence.
This is particularly relevant in the era of GLP-1 receptor agonists and other incretin-based weight-loss therapies.
These treatments can produce substantial improvements in body weight and cardiometabolic health. But reducing fat mass does not automatically demonstrate that all aspects of adipose tissue remodeling, vascular function, inflammatory resolution, or long-term adaptive capacity have been restored.
Nor should the goal simply be to stimulate greater fat burning. Excessive or poorly regulated lipolysis can itself contribute to metabolic dysfunction.
A more comprehensive objective would be to support healthy substrate handling, metabolic flexibility, and sustained physiological recovery.
Exercise is especially relevant because the review describes improvements in adipose vascularization, mitochondrial activity, and tissue organization that can occur even without substantial weight loss.
Appropriate nutrition, physical activity, sleep, and management of underlying medical conditions can support metabolic health, although no single intervention has been shown to repair every form of adipose dysfunction.
Rethinking Metabolic Health Beyond BMI
The emerging picture challenges the idea that metabolic health can be understood simply by classifying individuals according to body weight or BMI.
Two people with similar BMI may differ in fat distribution, adipocyte size, progenitor competence, vascular function, and insulin sensitivity.
The same individual may also experience changes in these characteristics with aging, illness, physical activity, or weight cycling.
This does not make BMI useless. It remains valuable for population-level assessment and as one component of individual risk evaluation.
But a more complete clinical assessment may consider waist circumference, body composition, glucose regulation, triglycerides, liver health, physical capacity, and changes over time.
No currently established clinical test directly measures an individual's precise personal fat threshold or bioenergetic impedance.
The important future research question is whether longitudinal assessments of fat distribution, lipid flux, adipose tissue remodeling, functional performance, and recovery can identify declining metabolic adaptability before overt disease develops.
Rather than asking only,
How much fat does this person have?
we might also ask:
How effectively can their adipose tissue accommodate the demands being placed upon it, and how well can it recover?
Conclusion: The Problem May Begin Before the Fat Becomes Excessive
The review by Drareni and Seale provides a valuable shift in understanding obesity and metabolic disease.
Fat accumulation is not inherently pathological. Adipose tissue evolved to buffer fluctuating energy availability and protect other organs from inappropriate lipid exposure.
Its ability to perform this role depends on coordinated cellular expansion, vascularization, substrate turnover, immune regulation, and tissue remodeling.
The Personal Fat Threshold hypothesis helps explain why metabolic dysfunction can develop at very different levels of body fat.
Our proposed bioenergetic perspective extends this discussion by asking whether that threshold also reflects a changing balance between physiological demand, adaptive capacity, and recovery.
As adipose tissue expands, its requirements for metabolic and structural support may increase. When those requirements can no longer be accommodated, compensatory responses may become persistent, lipid handling may deteriorate, and metabolic dysfunction may spread beyond adipose tissue itself.
The central issue may therefore be not simply how much energy the body stores, but whether its physiological systems retain the capacity to manage that energy without sacrificing long-term function.
The ultimate goal of metabolic health should extend beyond reducing the amount of fat we carry.
It should include preserving the ability of our tissues to respond, adapt, resolve, and recover.
References
Drareni, K., & Seale, P. (2026). When fat adapts: From physiological remodeling to disease. Science, 394(6824), 618–625. https://doi.org/10.1126/science.aee9044
Taylor, R., & Holman, R. R. (2015). Normal weight individuals who develop type 2 diabetes: The personal fat threshold. Clinical Science, 128(7), 405–410. https://doi.org/10.1042/CS20140553
Tippairote, T., Hoonkaew, P., Suksawang, A., & Tippairote, P. (2025). From adaptation to exhaustion: Defining exposure-related malnutrition as a bioenergetic phenotype of aging. Biogerontology, 26, Article 161. https://doi.org/10.1007/s10522-025-10302-2
Tippairote, T., & Hoonkaew, P. (2026). Bioenergetic impedance: A network physiology framework for stress adaptation, maladaptation, and recovery. Frontiers in Network Physiology, 6, Article 1967461. https://doi.org/10.3389/fnetp.2026.1967461





Comments